Skip to content

Neogen

US · NEOG #2579 by market cap Listed 1970
10.55 -0.30 -2.77%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 7 in the most recent period (2026/Q3).
  • Total institutional ownership (as a % of shares) was little changed.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
110.99% -0.01pp
Institutions
370 +7
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund77.45%
Public Company12.39%
Hedge Fund9.82%
Private Company7.90%
Government Pension Fund2.55%
Individual/Insider0.46%
Insurance Company0.44%
Family Office/Trust0.37%

Top holders as of 2026-09-30

BlackRock 15.11% · 32.98M sh
Neuberger Berman Investment Advisers LLC 7.59% · 16.57M sh
Vanguard Portfolio Management, LLC 5.94% · 12.97M sh
Dimensional Fund Advisors 4.71% · 10.28M sh
Vanguard Capital Management, LLC 4.43% · 9.67M sh
T. Rowe Price Group, Inc. 4.41% · 9.63M sh
SG Americas Securities, LLC 4.28% · 9.35M sh
State Street Global Advisors 4.08% · 8.92M sh
ING Groep N.V. 4.01% · 8.75M sh
Gates Capital Management, Inc. 4.00% · 8.74M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 37 buys · 9 sells

NameRoleStake
John Adent Former Chief Executive Officer 0.16%
James Borel Independent Chairperson 0.04%
David Naemura Former Officer 0.04%
Amy Rocklin Former Chief Legal & Compliance Officer and Corporate Secretary 0.04%
James Tobin Former Independent Director 0.02%
Jennifer Stacey Senior VP, Chief Legal & Compliance Officer and Board Secretary 0.02%
Gregory Hastings -- 0.02%
Jeffrey Capello Independent Director 0.02%
Rafael Rodriguez -- 0.01%
John Moylan Chief Accounting Officer 0.01%
Aashima Gupta Independent Director 0.01%
Catherine Woteki Independent Director 0.01%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-03 Jeremy Yarwood Chief Scientific Officer Derivative Exercise and Sale -16,207 $11.82–12.67
2026-11-03 Jeremy Yarwood Chief Scientific Officer Intent to Sell (Form 144) -9,051 $12.67
2026-11-01 Joe Freels Chief Commercial Officer Other Acquisition +6,345 $11.82
2026-11-01 Joe Freels Chief Commercial Officer Other Derivative Acquisition +31,311 $11.82
2026-10-28 Ronald Green Independent Director Derivative Exercise and Retained +1,776 $12.21
2026-10-28 Jeffrey Capello Independent Director Derivative Exercise and Retained +1,776 $12.21
2026-10-28 James Borel Independent Chairperson Derivative Exercise and Retained +1,776 $12.21
2026-10-28 Rafael Rodriguez -- Derivative Exercise and Retained +1,776 $12.21
2026-10-28 Catherine Woteki Independent Director Derivative Exercise and Retained +1,776 $12.21
2026-10-28 Aashima Gupta Independent Director Derivative Exercise and Retained +1,776 $12.21
2026-10-28 Gregory Hastings -- Derivative Exercise and Sale -337 $12.21
2026-10-28 Gregory Hastings -- Derivative Exercise and Retained +874 $12.21
2026-10-27 Thierry Bernard Former Independent Director Intent to Sell (Form 144) -16,937 $12.19
2026-10-13 Gregory Hastings -- Derivative Exercise and Sale -80 $12.00
2026-10-13 Gregory Hastings -- Derivative Exercise and Retained +207 $12.00
2026-09-30 Ronald Green Independent Director Other Acquisition +9,804 $12.24
2026-09-30 Ronald Green Independent Director Other Derivative Acquisition +20,558 $12.24
2026-09-30 Jeffrey Capello Independent Director Other Acquisition +9,804 $12.24
2026-09-30 Jeffrey Capello Independent Director Other Derivative Acquisition +20,558 $12.24
2026-09-30 James Borel Independent Chairperson Other Acquisition +9,804 $12.24

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Neogen discussion 0 comments

Add a comment